About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us
> Real-time Quotes & News

Real-time Quotes

Product
Bid
Ask
High
Low
Previous Close
*The above quotes are for reference only

Real-time News

2026-10-23

U.S. Central Command: Today marks the 100th day since U.S. Central Command forces reinstated the “Iron Wall” maritime blockade against Iran. This operation has helped prevent Iran from exporting at least $25 billion worth of crude oil and has limited

U.S. Central Command: Today marks the 100th day since U.S. Central Command forces reinstated the “Iron Wall” maritime blockade against Iran. This operation has helped prevent Iran from exporting at least $25 billion worth of crude oil and has limited the Islamic Revolutionary Guard Corps’ ability to fund proxy militias, criminal networks, and terrorism. Aside from humanitarian aid permitted by U.S. forces, Iran has not made any exports or imports by sea.
2026-10-23

Brent crude futures rose above $113/bbl, up more than 4% intraday.

Brent crude futures rose above $113/bbl, up more than 4% intraday.
2026-10-23

Brent crude oil futures broke through $113 per barrel, rising more than 4% on the day.

Brent crude oil futures broke through $113 per barrel, rising more than 4% on the day.
2026-10-23

The U.S. State Department imposes visa restrictions on 21 individuals from Colombia.

The U.S. State Department imposes visa restrictions on 21 individuals from Colombia.
2026-10-23

The U.S. State Department has imposed visa restrictions on 21 individuals from Colombia.

The U.S. State Department has imposed visa restrictions on 21 individuals from Colombia.
2026-10-23

Moderna (MRNA.O) shares tumbled as much as nearly 25% intraday on Thursday; Merck (MRK.N) fell 3.7%. Data from the experimental cancer vaccine the two firms are developing appears to have been posted early on medical site Oncology Central and was sub

Moderna (MRNA.O) shares tumbled as much as nearly 25% intraday on Thursday; Merck (MRK.N) fell 3.7%. Data from the experimental cancer vaccine the two firms are developing appears to have been posted early on medical site Oncology Central and was subsequently removed; the results had been scheduled for presentation at the European Society for Medical Oncology (ESMO) meeting on Saturday. The briefly posted data suggested the vaccine, administered with Merck’s Keytruda, reduced the risk of melanoma recurrence or death. Both companies had previously said the Phase III trial met its primary endpoint but have not published detailed results.
1 2 3 ... 288 Next
Real-time Quotes
Real-time News
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.